Biotricity (OTCMKTS:BTCY) Posts Earnings Results, Beats Estimates By $0.06 EPS

Biotricity (OTCMKTS:BTCY) released its earnings results on Wednesday. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06, Zacks reports.

Biotricity Stock Performance

OTCMKTS:BTCY traded up $0.06 during trading hours on Wednesday, reaching $0.66. The stock had a trading volume of 113,070 shares, compared to its average volume of 47,530. The stock has a market capitalization of $16.21 million, a PE ratio of -0.39 and a beta of 1.18. Biotricity has a 52 week low of $0.19 and a 52 week high of $1.67. The company has a 50 day moving average price of $0.35 and a two-hundred day moving average price of $0.36.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.